- Home
- SVII vs PEPG Comparison
SVII vs PEPG Comparison
Compare SVII & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- PEPG
- Stock Information
- Founded
- SVII 2021
- PEPG 2018
- Country
- SVII United States
- PEPG United States
- Employees
- SVII N/A
- PEPG N/A
- Industry
- SVII Blank Checks
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- SVII Finance
- PEPG Health Care
- Exchange
- SVII Nasdaq
- PEPG Nasdaq
- Market Cap
- SVII 252.5M
- PEPG 250.3M
- IPO Year
- SVII 2022
- PEPG 2022
- Fundamental
- Price
- SVII $11.70
- PEPG $4.83
- Analyst Decision
- SVII
- PEPG Strong Buy
- Analyst Count
- SVII 0
- PEPG 2
- Target Price
- SVII N/A
- PEPG $23.00
- AVG Volume (30 Days)
- SVII 185.0K
- PEPG 39.9K
- Earning Date
- SVII 01-01-0001
- PEPG 11-07-2024
- Dividend Yield
- SVII N/A
- PEPG N/A
- EPS Growth
- SVII 36.87
- PEPG N/A
- EPS
- SVII 0.37
- PEPG N/A
- Revenue
- SVII N/A
- PEPG N/A
- Revenue This Year
- SVII N/A
- PEPG N/A
- Revenue Next Year
- SVII N/A
- PEPG N/A
- P/E Ratio
- SVII $31.61
- PEPG N/A
- Revenue Growth
- SVII N/A
- PEPG N/A
- 52 Week Low
- SVII $10.75
- PEPG $3.72
- 52 Week High
- SVII $11.70
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- SVII 87.32
- PEPG 24.14
- Support Level
- SVII $11.38
- PEPG $6.36
- Resistance Level
- SVII $11.37
- PEPG $7.50
- Average True Range (ATR)
- SVII 0.03
- PEPG 0.52
- MACD
- SVII 0.02
- PEPG -0.16
- Stochastic Oscillator
- SVII 100.00
- PEPG 3.21
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.